Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Immunoescape the link between emphysema and lung cancer?

Sauleda J, Verdú FJ, Scrimini S, Sala E, Pons J.

J Thorac Dis. 2019 Mar;11(Suppl 3):S329-S330. doi: 10.21037/jtd.2018.12.133. No abstract available.

2.

Physical Activity Is Associated with Attenuated Disease Progression in Chronic Obstructive Pulmonary Disease.

Demeyer H, Donaire-Gonzalez D, Gimeno-Santos E, Ramon MA, DE Battle J, Benet M, Serra I, Guerra S, Farrero E, Rodriguez E, Ferrer J, Sauleda J, Monso E, Gea J, Rodriguez-Roisin R, Agusti A, Antó JM, Garcia-Aymerich J.

Med Sci Sports Exerc. 2019 May;51(5):833-840. doi: 10.1249/MSS.0000000000001859.

PMID:
30531289
3.

Idiopathic Pulmonary Fibrosis: Epidemiology, Natural History, Phenotypes.

Sauleda J, Núñez B, Sala E, Soriano JB.

Med Sci (Basel). 2018 Nov 29;6(4). pii: E110. doi: 10.3390/medsci6040110. Review.

4.

Importance of early diagnosis and treatment in idiopathic pulmonary fibrosis.

Molina-Molina M, Aburto M, Acosta O, Ancochea J, Rodríguez-Portal JA, Sauleda J, Lines C, Xaubet A.

Expert Rev Respir Med. 2018 Jul;12(7):537-539. doi: 10.1080/17476348.2018.1472580. Epub 2018 May 7. No abstract available.

PMID:
29718749
5.

Functional respiratory assessment before lung volume reduction in patients with emphysema.

Verdú J, Cosío BG, Sauleda J.

Arch Bronconeumol. 2018 May;54(5):251-252. doi: 10.1016/j.arbres.2017.11.001. Epub 2017 Dec 16. English, Spanish. No abstract available.

6.

Usefulness of Bronchoscopic Probe-Based Confocal Laser Endomicroscopy in the Diagnosis of Pneumocystis jirovecii Pneumonia.

Shafiek H, Fiorentino F, Cosio BG, Kersul A, Thiberville L, Gómez C, Riera M, Martín ML, Martínez R, Noguera MA, Agustí A, Sauleda J.

Respiration. 2016;92(1):40-7. doi: 10.1159/000447431. Epub 2016 Jul 1.

7.

Risk of postoperative complications in chronic obstructive lung diseases patients considered fit for lung cancer surgery: beyond oxygen consumption.

Shafiek H, Valera JL, Togores B, Torrecilla JA, Sauleda J, Cosío BG.

Eur J Cardiothorac Surg. 2016 Oct;50(4):772-779. Epub 2016 Apr 7.

PMID:
27059429
8.

Lack of Correlation Between Pulmonary and Systemic Inflammation Markers in Patients with Chronic Obstructive Pulmonary Disease: A Simultaneous, Two-Compartmental Analysis.

Núñez B, Sauleda J, Garcia-Aymerich J, Noguera A, Monsó E, Gómez F, Barreiro E, Marín A, Antó JM, Agusti A; Miembros del Grupo de Trabajo sobre la Caracterización Fenotípica y Evolución de la EPOC (PAC-COPD).

Arch Bronconeumol. 2016 Jul;52(7):361-7. doi: 10.1016/j.arbres.2016.01.003. Epub 2016 Feb 24. English, Spanish.

9.

Prevalence and Perception of 24-Hour Symptom Patterns in Patients With Stable Chronic Obstructive Pulmonary Disease in Spain.

Soler-Cataluña JJ, Sauleda J, Valdés L, Marín P, Agüero R, Pérez M, Miravitlles M.

Arch Bronconeumol. 2016 Jun;52(6):308-15. doi: 10.1016/j.arbres.2015.11.010. Epub 2016 Jan 7. English, Spanish.

10.

Inspiratory capacity-to-total lung capacity ratio and dyspnoea predict exercise capacity decline in COPD.

Ramon MA, Ferrer J, Gimeno-Santos E, Donaire-Gonzalez D, Rodríguez E, Balcells E, de Batlle J, Benet M, Guerra S, Sauleda J, Ferrer A, Farrero E, Gea J, Barberà JA, Agustí A, Rodriguez-Roisin R, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

Respirology. 2016 Apr;21(3):476-82. doi: 10.1111/resp.12723. Epub 2015 Dec 30.

11.

Myeloid-Derived Suppressor Cells: Possible Link Between Chronic Obstrucive Pulmonary Disease and Lung Cancer.

Scrimini S, Pons J, Sauleda J.

Arch Bronconeumol. 2016 Jan;52(1):29-35. doi: 10.1016/j.arbres.2015.07.003. Epub 2015 Aug 29. Review. English, Spanish.

12.

Benefits of physical activity on COPD hospitalisation depend on intensity.

Donaire-Gonzalez D, Gimeno-Santos E, Balcells E, de Batlle J, Ramon MA, Rodriguez E, Farrero E, Benet M, Guerra S, Sauleda J, Ferrer A, Ferrer J, Barberà JA, Rodriguez-Roisin R, Gea J, Agustí A, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

Eur Respir J. 2015 Nov;46(5):1281-9. doi: 10.1183/13993003.01699-2014. Epub 2015 Jul 23.

13.

Expansion of myeloid-derived suppressor cells in chronic obstructive pulmonary disease and lung cancer: potential link between inflammation and cancer.

Scrimini S, Pons J, Agustí A, Clemente A, Sallán MC, Bauçà JM, Soriano JB, Cosio BG, Lopez M, Crespi C, Sauleda J.

Cancer Immunol Immunother. 2015 Oct;64(10):1261-70. doi: 10.1007/s00262-015-1737-x. Epub 2015 Jun 28.

PMID:
26122358
14.

B Cell-Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease.

Polverino F, Cosio BG, Pons J, Laucho-Contreras M, Tejera P, Iglesias A, Rios A, Jahn A, Sauleda J, Divo M, Pinto-Plata V, Sholl L, Rosas IO, Agustí A, Celli BR, Owen CA.

Am J Respir Crit Care Med. 2015 Sep 15;192(6):695-705. doi: 10.1164/rccm.201501-0107OC.

15.

Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation.

Balcells E, Gimeno-Santos E, de Batlle J, Ramon MA, Rodríguez E, Benet M, Farrero E, Ferrer A, Guerra S, Ferrer J, Sauleda J, Barberà JA, Agustí À, Rodriguez-Roisin R, Gea J, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

BMC Pulm Med. 2015 Jan 17;15:4. doi: 10.1186/1471-2466-15-4.

16.

Probe-based confocal laser endomicroscopy imaging of endobronchial hamartomas.

Shafiek H, Gómez C, Pierola J, Sauleda J, Cosío BG.

Respiration. 2014;88(6):484-6. doi: 10.1159/000368085. Epub 2014 Nov 14.

17.

Determinants of false-negative results in non-small-cell lung cancer staging by endobronchial ultrasound-guided needle aspiration.

Sanz-Santos J, Serra M, Gallego M, Montón C, Cosio B, Sauleda J, Fernández-Villar A, García-Luján R, de Miguel E, Cordovilla R, Varela G, Cases E, Andreo F, Monsó E.

Eur J Cardiothorac Surg. 2015 Apr;47(4):642-7. doi: 10.1093/ejcts/ezu253. Epub 2014 Jul 8.

PMID:
25005839
18.

Determinants of exercise capacity in obese and non-obese COPD patients.

Rodríguez DA, Garcia-Aymerich J, Valera JL, Sauleda J, Togores B, Galdiz JB, Gea J, Orozco-Levi M, Ferrer A, Gomez FP, Barberà JA, Serra I, Antó JM, Roca J; PAC-COPD Study Group.

Respir Med. 2014 May;108(5):745-51. doi: 10.1016/j.rmed.2014.02.004. Epub 2014 Feb 12.

19.

Air pollution and biomarkers of systemic inflammation and tissue repair in COPD patients.

Dadvand P, Nieuwenhuijsen MJ, Agustí À, de Batlle J, Benet M, Beelen R, Cirach M, Martinez D, Hoek G, Basagaña X, Ferrer A, Ferrer J, Rodriguez-Roisin R, Sauleda J, Guerra S, Antó JM, Garcia-Aymerich J.

Eur Respir J. 2014 Sep;44(3):603-13. doi: 10.1183/09031936.00168813. Epub 2014 Feb 20.

20.

Real-time prediction of mediastinal lymph node malignancy by endobronchial ultrasound.

Shafiek H, Fiorentino F, Peralta AD, Serra E, Esteban B, Martinez R, Noguera MA, Moyano P, Sala E, Sauleda J, Cosío BG.

Arch Bronconeumol. 2014 Jun;50(6):228-34. doi: 10.1016/j.arbres.2013.12.002. Epub 2014 Feb 8. English, Spanish.

21.

Structure-function relationship in COPD revisited: an in vivo microscopy view.

Cosío BG, Shafiek H, Fiorentino F, Gómez C, López M, Rios A, Kersul A, Togores B, Palmer J, Sauleda J, Agustí A.

Thorax. 2014 Aug;69(8):724-30. doi: 10.1136/thoraxjnl-2013-204479. Epub 2014 Jan 29.

PMID:
24477204
22.

Hospital admissions and exercise capacity decline in patients with COPD.

Ramon MA, Gimeno-Santos E, Ferrer J, Balcells E, Rodríguez E, de Batlle J, Gómez FP, Sauleda J, Ferrer A, Barberà JA, Agustí A, Gea J, Rodriguez-Roisin R, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

Eur Respir J. 2014 Apr;43(4):1018-27. doi: 10.1183/09031936.00088313. Epub 2014 Jan 3.

23.

Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapy.

Sampériz G, Guerrero D, López M, Valera JL, Iglesias A, Ríos A, Campins A, Sala E, Murillas J, Togores B, Palmer J, Rodriguez M, Soriano JB, Sauleda J, Riera M, Agusti A.

HIV Med. 2014 Jul;15(6):321-9. doi: 10.1111/hiv.12117. Epub 2013 Dec 8.

24.

Differential effects of smoking and COPD upon circulating myeloid derived suppressor cells.

Scrimini S, Pons J, Agustí A, Soriano JB, Cosio BG, Torrecilla JA, Núñez B, Córdova R, Iglesias A, Jahn A, Crespi C, Sauleda J.

Respir Med. 2013 Dec;107(12):1895-903. doi: 10.1016/j.rmed.2013.08.002. Epub 2013 Aug 28.

25.

HLA distribution in COPD patients.

Faner R, Nuñez B, Sauleda J, Garcia-Aymerich J, Pons J, Crespí C, Milà J, González JR, Maria Antó J, Agusti A; PAC-COPD Study Group.

COPD. 2013 Apr;10(2):138-46. doi: 10.3109/15412555.2012.729621. Epub 2013 Mar 20.

PMID:
23514216
26.

Specific IgA and metalloproteinase activity in bronchial secretions from stable chronic obstructive pulmonary disease patients colonized by Haemophilus influenzae.

Millares L, Marin A, Garcia-Aymerich J, Sauleda J, Belda J, Monsó E; PAC-COPD Study Group.

Respir Res. 2012 Dec 11;13:113. doi: 10.1186/1465-9921-13-113.

27.

Monitoring breathing rate at home allows early identification of COPD exacerbations.

Yañez AM, Guerrero D, Pérez de Alejo R, Garcia-Rio F, Alvarez-Sala JL, Calle-Rubio M, de Molina RM, Valle Falcones M, Ussetti P, Sauleda J, García EZ, Rodríguez-González-Moro JM, Franco Gay M, Torrent M, Agustí A.

Chest. 2012 Dec;142(6):1524-1529. doi: 10.1378/chest.11-2728.

PMID:
22797131
28.

Effect of bronchial colonisation on airway and systemic inflammation in stable COPD.

Marin A, Garcia-Aymerich J, Sauleda J, Belda J, Millares L, García-Núñez M, Serra I, Benet M, Agustí A, Antó JM, Monsó E; PAC-COPD Study Group.

COPD. 2012 Apr;9(2):121-30. doi: 10.3109/15412555.2011.636407.

PMID:
22458940
29.

Consensus document on the overlap phenotype COPD-asthma in COPD.

Soler-Cataluña JJ, Cosío B, Izquierdo JL, López-Campos JL, Marín JM, Agüero R, Baloira A, Carrizo S, Esteban C, Galdiz JB, González MC, Miravitlles M, Monsó E, Montemayor T, Morera J, Ortega F, Peces-Barba G, Puente L, Rodríguez JM, Sala E, Sauleda J, Soriano JB, Viejo JL.

Arch Bronconeumol. 2012 Sep;48(9):331-7. Epub 2012 Feb 15. English, Spanish.

30.

Association between Ω3 and Ω6 fatty acid intakes and serum inflammatory markers in COPD.

de Batlle J, Sauleda J, Balcells E, Gómez FP, Méndez M, Rodriguez E, Barreiro E, Ferrer JJ, Romieu I, Gea J, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

J Nutr Biochem. 2012 Jul;23(7):817-21. doi: 10.1016/j.jnutbio.2011.04.005. Epub 2011 Sep 1.

PMID:
21889886
31.

Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.

Garcia-Aymerich J, Gómez FP, Benet M, Farrero E, Basagaña X, Gayete À, Paré C, Freixa X, Ferrer J, Ferrer A, Roca J, Gáldiz JB, Sauleda J, Monsó E, Gea J, Barberà JA, Agustí À, Antó JM; PAC-COPD Study Group.

Thorax. 2011 May;66(5):430-7. doi: 10.1136/thx.2010.154484. Epub 2010 Dec 21.

32.

Anti-tissue antibodies are related to lung function in chronic obstructive pulmonary disease.

Núñez B, Sauleda J, Antó JM, Julià MR, Orozco M, Monsó E, Noguera A, Gómez FP, Garcia-Aymerich J, Agustí A; PAC-COPD Investigators.

Am J Respir Crit Care Med. 2011 Apr 15;183(8):1025-31. doi: 10.1164/rccm.201001-0029OC. Epub 2010 Nov 19.

PMID:
21097696
33.

Variability and effects of bronchial colonisation in patients with moderate COPD.

Marin A, Monsó E, Garcia-Nuñez M, Sauleda J, Noguera A, Pons J, Agustí A, Morera J.

Eur Respir J. 2010 Feb;35(2):295-302. doi: 10.1183/09031936.00126808. Epub 2009 Jul 30.

34.

Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke.

Martí-Lliteras P, Regueiro V, Morey P, Hood DW, Saus C, Sauleda J, Agustí AG, Bengoechea JA, Garmendia J.

Infect Immun. 2009 Oct;77(10):4232-42. doi: 10.1128/IAI.00305-09. Epub 2009 Jul 20.

35.

Physical activity and clinical and functional status in COPD.

Garcia-Aymerich J, Serra I, Gómez FP, Farrero E, Balcells E, Rodríguez DA, de Batlle J, Gimeno E, Donaire-Gonzalez D, Orozco-Levi M, Sauleda J, Gea J, Rodriguez-Roisin R, Roca J, Agustí ÀG, Antó JM; Phenotype and Course of COPD (PAC-COPD) Study Group.

Chest. 2009 Jul;136(1):62-70. doi: 10.1378/chest.08-2532. Epub 2009 Mar 2.

PMID:
19255291
36.

[Phenotypic heterogeneity of chronic obstructive pulmonary disease].

Garcia-Aymerich J, Agustí A, Barberà JA, Belda J, Farrero E, Ferrer A, Ferrer J, Gáldiz JB, Gea J, Gómez FP, Monsó E, Morera J, Roca J, Sauleda J, Antó JM; en nombre del Grupo de Trabajo sobre la Caracterización Fenotípica y Evolución de la Enfermedad Pulmonar Obstructiva Crónica (PAC-COPD).

Arch Bronconeumol. 2009 Mar;45(3):129-38. doi: 10.1016/j.arbres.2008.10.001. Epub 2009 Feb 25. Review. Spanish.

37.

Lipopolysaccharide-binding protein and CD14 are increased in the bronchoalveolar lavage fluid of smokers.

Regueiro V, Campos MA, Morey P, Sauleda J, Agustí AG, Garmendia J, Bengoechea JA.

Eur Respir J. 2009 Feb;33(2):273-81. doi: 10.1183/09031936.00087708. Epub 2008 Nov 14.

38.

Systemic inflammation after inspiratory loading in chronic obstructive pulmonary disease.

Fuster A, Sauleda J, Sala E, Barceló B, Pons J, Carrera M, Noguera A, Togores B, Agustí AG.

Int J Chron Obstruct Pulmon Dis. 2008;3(1):149-53.

39.

Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease.

Busquets X, MacFarlane NG, Heine-Suñer D, Morlá M, Torres-Juan L, Iglesias A, Lladó J, Sauleda J, Agustí AG.

Int J Chron Obstruct Pulmon Dis. 2007;2(3):329-34.

40.

Pulmonary and systemic hepatocyte and keratinocyte growth factors in patients with chronic obstructive pulmonary disease.

Sauleda J, Noguera A, Blanquer D, Pons J, López M, Villena C, Agustí AG.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):719-25.

41.

Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking.

Barceló B, Pons J, Ferrer JM, Sauleda J, Fuster A, Agustí AG.

Eur Respir J. 2008 Mar;31(3):555-62. Epub 2007 Dec 5.

42.

[Reduced expression of the sarcoplasmic calcium pump SERCA2 in skeletal muscle from patients with chronic obstructive pulmonary disease and low body weight].

Morlà M, Iglesias A, Sauleda J, Cosio B, Agustí A, Busquets X.

Arch Bronconeumol. 2007 Jan;43(1):4-8. Spanish.

43.

Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease.

Barceló B, Pons J, Fuster A, Sauleda J, Noguera A, Ferrer JM, Agustí AG.

Clin Exp Immunol. 2006 Sep;145(3):474-9.

44.

Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease.

Pons J, Sauleda J, Regueiro V, Santos C, López M, Ferrer J, Agustí AG, Bengoechea JA.

Respir Res. 2006 Apr 10;7:64.

45.

Telomere shortening in smokers with and without COPD.

Morlá M, Busquets X, Pons J, Sauleda J, MacNee W, Agustí AG.

Eur Respir J. 2006 Mar;27(3):525-8.

46.

Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections.

Maciá MD, Blanquer D, Togores B, Sauleda J, Pérez JL, Oliver A.

Antimicrob Agents Chemother. 2005 Aug;49(8):3382-6.

47.

Decreased macrophage release of TGF-beta and TIMP-1 in chronic obstructive pulmonary disease.

Pons AR, Sauleda J, Noguera A, Pons J, Barceló B, Fuster A, Agustí AG.

Eur Respir J. 2005 Jul;26(1):60-6.

48.

Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD.

Pons AR, Noguera A, Blanquer D, Sauleda J, Pons J, Agustí AG.

Eur Respir J. 2005 Apr;25(4):647-52.

49.

Oxidative stress and airway inflammation in severe exacerbations of COPD.

Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, Agusti A, MacNee W.

Thorax. 2005 Apr;60(4):293-300.

50.

Blunted gamma delta T-lymphocyte response in chronic obstructive pulmonary disease.

Pons J, Sauleda J, Ferrer JM, Barceló B, Fuster A, Regueiro V, Julià MR, Agustí AG.

Eur Respir J. 2005 Mar;25(3):441-6.

Supplemental Content

Loading ...
Support Center